Takeda Pharmaceutical Company

[12] One of the firm's mainstay drugs is Actos (pioglitazone), a compound in the... in cancer drug research, for US$8.8 billion.[16] The acquisition brought in Velcade, a drug indicated for...

Takeda, Lilly Jury Awards $9 Billion Over Actos Risks - Bloomberg

Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages after a federal court jury found they hid the cancer risks of their Actos diabetes medici...

Actos Injury Attorney | Actos Class Action Lawyer Cleveland

Bladder cancer after taking Actos for Type 2 Diabetes? Call Actos Injury Attorney, Tim Misny 877.944.43733 and I’ll Make Them Pay!®

Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug Actos

Pharmaceutical companies Eli Lilly and Takeda are facing a class-action lawsuit over their diabetes drug Actos, which has been certified by a California Federal Judge. The case claims that the drug...

Biggest Pharmaceutical Lawsuits: Cases That Shaped the Industry

Procrit treats anaemia in cancer patients, whereas Amgen misbranded Aranesp to be treating anaemic cancer patients. The FDA... prostate cancer drug, Lupron. Credit: momboleum. TAP paid...

Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evidence

bladder cancer in male rats (but not in female rats, mice... bladder cancer and exposure to pioglitazone in patients. A 5... bladder cancer and pioglitazone, even after >4years of exposure...

[논문]Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evid

bladder cancer in male rats (but not in female rats, mice... bladder cancer and exposure to pioglitazone in patients. A 5... bladder cancer and pioglitazone, even after >4years of exposure...

Actos | Side Effects, FDA Warnings and International Recalls

People with Type 2 diabetes take Actos to regulate blood sugar levels, but taking the drug at high doses for a long time may raise the risk of bladder cancer.

Takeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of Actos - The New York Times

Takeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of Actos Share full article A Takeda Pharmaceuticals plant in Oranienburg, Germany. In its settlement agreement covering...

FDA Drug Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk....

Facts about pioglitazone ; Sold as a single-ingredient product under the brand-name Actos. Also sold in combination with metformin (Actoplus Met, Actoplus Met XR) and glimepiride (Duetact). ; Used along with diet and exercise to improve control of blood sugar in adults with type 2 diabetes mellitus. ; From January 2010 through October 2010, approximately 2.3 million patients filled a prescription for a pioglitazone-containing product from outpatient retail pharmacies.2